Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Center for Cell Therapy (CCT) is a Czech biotechnology company focused on the development and clinical application of stem cell-based therapies. Through its subsidiary, Bioinova, the company develops autologous and allogeneic mesenchymal stem cell (MSC) products derived from bone marrow and adipose tissue. Its lead programs are in Phase 2 clinical trials for indications such as Amyotrophic Lateral Sclerosis (ALS) and Osteoarthritis. CCT also operates a GMP-certified manufacturing facility and collaborates with academic institutions like the Institute of Experimental Medicine of the CAS. The company aims to provide innovative solutions for regenerative medicine and chronic inflammatory diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Cell Therapy.